Advances in the Research and Development of Chemotherapeutic Agents for Respiratory Tract Bacterial Infections

Author： Cazzola M.   Blasi F.   Centanni S.   Donner C.F.   Allegra L.  

Publisher： Academic Press

ISSN： 1094-5539

Source： Pulmonary Pharmacology & Therapeutics, Vol.14, Iss.5, 2001-10, pp. : 367-381

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Moxifloxacin in respiratory tract infections

By Miravitlles Marc  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 2, 2005-02 ,pp. : 283-293

Informa Healthcare

Access to resources Recommend Favorite

Reducing morbidity in respiratory tract infections

By  

Inpharma, Vol. 1, Iss. 1232, 2000-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Azithromycin and lower respiratory tract infections

By Blasi F   Cazzola M   Tarsia P   Cosentini R   Aliberti S   Santus P   Allegra L  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2335-2351

Informa Healthcare

Access to resources Recommend Favorite

Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycin

By Nicolau David P  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 229-235

Informa Healthcare

Access to resources Recommend Favorite

Cefditoren pivoxil: a guide to its use in the treatment of bacterial infections of the respiratory tract or skin and skin structures

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 9, 2008-09 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite